Friday, March 16, 2012

Why Investors Needn’t Fear the ‘Patent Cliff’

XCSFDHG46767FHJHJF

tdp2664 InvestorPlace Expiring drug patents can cost pharma stocks billions of dollars, but companies and investors alike can prepare themselves well in advance.



No comments:

Post a Comment

LinkWithin

Related Posts Plugin for WordPress, Blogger...